Tag: Vaccines
ACAAI Updates Guidance for Allergic Reactions to COVID-19 Vaccines
Guidance relates to risks for allergic reactions for mRNA (Moderna and Pfizer) and adenovirus vector (Johnson & Johnson) COVID-19 vaccines
ChAdOx1 nCoV-19 Vaccine Does Not Protect Against B.1.351 SARS-CoV-2 Variant
Vaccine efficacy was 10.4 percent against the B.1.351 variant of SARS-CoV-2, first described in South Africa
AstraZeneca Vaccine Safe and Effective, European Medicines Agency Says
Officials hope announcement will ease concerns about possible rare side effects involving blood clots
Florida Baby First in U.S. Born With COVID-19 Antibodies
Mother received her first shot of the Moderna COVID-19 vaccine when she was 36 weeks pregnant
Most People Complete Two-Dose COVID-19 Vaccination Series
Of those receiving a second COVID-19 vaccine dose, 95.6 percent did so within the recommended interval
States Broaden COVID-19 Vaccine Access to Millions of Americans
At the beginning of the rollout, vaccines were available only to the most vulnerable Americans and some essential workers
Partial Pfizer COVID-19 Vaccination 63 Percent Effective
Estimated effectiveness 63 percent for period from more than 14 days after the first dose through seven days after the second dose
Moderna Starts Testing COVID-19 Vaccine in Younger Children
Company also testing its vaccine in 3,000 older children, ages 12 to 17 years
AstraZeneca Says Its COVID-19 Vaccine Is Safe, Despite Reports of Deadly Clots
The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain
COVID-19 Vaccines Given to Americans Top 100 Million
As of Monday, more than 37.4 million Americans are now fully vaccinated, 11.3 percent of the total population
